Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'
Go back to Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'| Amgen Inc (NASDAQ: AMGN) | Delayed: 269.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $269.38 | 52 Week High | $176.85 | |||
| Open | $269.38 | 52 Week Low | $133.64 | |||
| Day High | $269.38 | P/E | 40.57 | |||
| Day Low | $269.38 | EPS | $6.64 | |||
| Volume | 6 | |||||
